ESC 365 - The role of the ESC Health Policy: relevance to electrophysiology and cardiac device practice.

EHRA Premium Access

The role of the ESC Health Policy: relevance to electrophysiology and cardiac device practice.

Session: Is it worth the money? Cost-effectiveness in electrophysiology

Topic: Policy initiative

Speaker: Professor P. Vardas (Heraklion, GR)

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

About the speaker

Professor Panagiotis Vardas

University Hospital of Heraklion, Heraklion (Greece)

19 presentations

1 follower

3 more presentations in this session

Comparative cost-effectiveness of atrial fibrillation ablation versus pharmacological therapy.

Speaker: Doctor J. Caldwell (Hull, GB)

Patient compliance and outcomes of pharmacological therapy and atrial fibrillation ablation.

Speaker: Professor S. Saksena (Warren, US)

Commissioning and reimbursement of atrial fibrillation ablation in Europe.

Speaker: Professor F. Braunschweig (Stockholm, SE)

Access the full session

Is it worth the money? Cost-effectiveness in electrophysiology

Speakers: Professor P. Vardas, Doctor J. Caldwell, Professor S. Saksena, Professor F. Braunschweig

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources